Preferences of biobank participants for receiving actionable genomic test results: results of a recontacting study
- 18 February 2021
- journal article
- research article
- Published by Elsevier BV in Genetics in Medicine
- Vol. 23 (6), 1163-1166
- https://doi.org/10.1038/s41436-021-01111-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancerESMO Open, 2020
- Harmonizing Clinical Sequencing and Interpretation for the eMERGE III NetworkAmerican Journal of Human Genetics, 2019
- Informed Consent in Translational Genomics: Insufficient Without Trustworthy GovernanceThe Journal of Law, Medicine & Ethics, 2018
- Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studiesGenetics in Medicine, 2017
- Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing researchEuropean Journal of Human Genetics, 2015
- Models of Consent to Return of Incidental Findings in Genomic ResearchHastings Center Report, 2014
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?AJOB Primary Research, 2012
- The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studiesBMC Medical Genomics, 2011
- Glad You Asked: Participants' Opinions of Re-Consent for DbGap Data SubmissionJournal of Empirical Research on Human Research Ethics, 2010